FNY Managed Accounts’s Aegerion Pharmaceuticals AEGR Stock Holding History

FNY Managed Accounts’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-49,372	Closed	-$147K	–	409
2016 Q3	$147K	Buy	49,372 +28,972	+142%	+$50.2K	0.12%	110
2016 Q2	$30.4K	Buy	+20,400	New	+$46.7K	0.03%	147
2015 Q3	–	Sell	-5,000	Closed	-$94.8K	–	666
2015 Q2	$94.8K	Buy	+5,000	New	+$108K	0.11%	117

FNY Managed Accounts's AEGR Position: Q4 2016 in Review

FNY Managed Accounts sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 49,372 shares — an estimated $147K sold.

FNY Managed Accounts first reported a position in AEGR in Q2 2015 and held it in 3 quarters. The position peaked at $147K in Q3 2016. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

FNY Managed Accounts reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
FNY Managed Accounts sold 49,372 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $147K.
FNY Managed Accounts first reported a position in Aegerion Pharmaceuticals in Q2 2015 and held it in 3 quarters.
FNY Managed Accounts's Aegerion Pharmaceuticals position peaked at $147K in Q3 2016.
0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on FNY Managed Accounts's 13F filing for Q4 2016, filed 8 Feb 2017.